Document is current
Any future updates will be listed below
-
Authors
Bado, Patricia https://orcid.org/0000-0001-8543-2547
Schafer, Julia
Simioni, Andre R.
Bressan, Rodrigo A.
Gadelha, Ary
Pan, Pedro M.
Miguel, Eurípedes C.
Rohde, Luis A.
Salum, Giovanni A.
-
Funding
Funding for this research was provided by:
National Institute of Developmental Psychiatry for Children and Adolescents, CNPQ (grant number 573974/2008-0)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
National Institute of Mental Health (RO1 MH120482-01, subarawrd nº 576811)
- License Information
-
More Information
Article History
Received: 1 July 2020
Accepted: 24 October 2020
First Online: 11 November 2020
Compliance with ethical standards
:
: Patricia Bado, Julia Schafer, Andre R. Simioni, Eurípedes C. Miguel and Giovanni A. Salum declare no conflict of interest. Rodrigo A. Bressan has received personal fees and non-financial support from Janssen, personal fees from Pfizer, Torrent and Sanofi-Aventis outside the submitted work; Ary Gadelha has been a speaker and/or advisor to or has received honoraria from Janssen, Daiichi-Sankyo, Aché, Cristália and Torrent; Luis Augusto Rohde has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Medice, Novartis/Sandoz and Shire/Takeda in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr Rohde have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Novartis/Sandoz and Shire/Takeda. Dr Rohde has received authorship royalties from Oxford Press and ArtMed and travel grants from Shire to take part in the 2018 APA annual meeting.
